Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

David Flacks chairs Upside Biotechnologies

February 20, 2017. AUCKLAND, NEW ZEALAND

MEDIA RELEASE

David Flacks chairs Upside Biotechnologies

Regenerative medicine company, Upside Biotechnologies, has appointed lawyer and experienced director David Flacks as Board chair.

The Auckland-based company is developing an advanced, world-class skin replacement treatment for patients suffering major burns.

Mr Flacks was, for many years, a senior corporate partner of Bell Gully and was also general counsel and company secretary of Carter Holt Harvey in the 1990's. He is chair of NZX listed AFT Pharmaceuticals and P2P platform Harmoney. He is also a director of NZ VIF, Vero Insurance and a number of charitable organisations. He is an active angel investor.

“I am extremely happy that David has joined the Board as chair. David brings exceptionally deep governance experience, excellent networks and sector knowledge through his role as chair of AFT Pharmaceuticals,” says Upside’s chief executive officer Dr Robert Feldman.

“Good governance makes a real difference to the success of a company and having David on board helps us achieve the right governance structure. The company not only benefits from appointing an excellent Board chair but we also gain David’s enthusiasm for Upside and what it is doing.”

Mr Flacks says, “This is an exciting development for a New Zealand-based biotech and I am delighted to be involved with Robert and the great team of scientists led by Professor Rod Dunbar and Dr Vaughan Feisst.”

He will join Cure Kids Ventures CEO Maxine Simmons and Will Charles, Auckland Uniservices’ general manager of Technology Development, on the Upside Board.

Ends



© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Fish & Game Support: Canterbury Officer Of Health Warns On Nitrates In Water

"Nitrate testing of 114 drinking water samples from across the Canterbury plains showed that more than half of them were above the level considered safe in the world's largest ever study on the impacts of nitrates in drinking water." More>>

ALSO:

Partnerships Investment Round: Government Invests In Cancer Research, Pines, Ryegrass

The Government will invest $14.4 million into transformative new scientific research programmes including cutting-edge cancer treatment and vertical farming, Research, Science and Innovation Minister Megan Woods announced today. More>>

ALSO:

Stats: Net Migration Remains High

“Since late 2014, annual net migration has ranged between 48,000 and 64,000,” population indicators manager Tehseen Islam said. “The only previous time net migration was at these levels was for a short period in the early 2000s.” More>>

ALSO:

Retail: Costco To Open First NZ Store At Westgate In Auckland

American multi-national discount store operator Costco Wholesale is planning to open its first New Zealand store at the Westgate shopping centre in Auckland’s north-west. More>>

ALSO:

RNZ Report: Fungal Disease Claims Life Of Seventh Kākāpō

A seventh kākāpō being treated for the respiratory disease aspergillosis has died. Nora 1-A was just over 100 days old and was the sickest of the kākāpō being treated at the New Zealand Centre Conservation Medicine at Auckland Zoo. More>>